Related Terms :
- Deep Vein Thrombosis
- Saphenous Thrombophlebitis
- Superficial Phlebitis
Proposed Natural Treatments for Phlebitis/DVT
1 Seligman B. Bromelain: an anti-inflammatory agent. Angiology. 1962;13:508-510.
2 Seligman B. Oral bromelains as adjuncts in the treatment of acute thrombophlebitis. Angiology. 1969;20:22-26.
3 Taussig SJ, Yokoyama MM, Chinen A, et al. Bromelain: a proteolytic enzyme and its clinical application. A review. Hiroshima J Med Sci. 1975;24:185-193.
4 Scondotto G, De Fabritiis A, Guastarobba A, et al. The use of a minor fibrinolytic drug (Mesoglycan) in phlebopathies [in Italian; English abstract]. Minerva Med . 1984;75:1733-1738.
5 Prandoni P, Cattelan AM, Carta M. Long-term sequelae of deep venous thrombosis of the legs. Experience with mesoglycan [in Italian; English abstract]. Ann Ital Med Int. 1989;4:378-385.
6 ten Wolde M, Kraaijenhagen RA, et al. Travel and the risk of symptomatic venous thromboembolism. Thromb Haemost. 2003;89:499-505.
7 Putter M, Grotemeyer KH, Wurthwein G, et al. Inhibition of smoking-induced platelet aggregation by aspirin and pycnogenol. Thromb Res . 1999;95:155-161.
8 Belcaro G, Cesarone MR, Rohdewald P, et al. Prevention of venous thrombosis and thrombophlebitis in long-haul flights with Pycnogenol. Clin Appl Thromb Hemost . 2004;10:373-7.
9 Cesarone MR, Belcaro G, Nicolaides AN, et al. Prevention of venous thrombosis in long-haul flights with Flite Tabs: the LONFLIT-FLITE randomized, controlled trial. Angiology. 2003;54:531-539.
10 Ray JG, Kearon C, Yi Q, et al. Homocysteine-lowering therapy and risk for venous thromboembolism. Ann Intern Med. 2007;146:761-767.
11 Glynn RJ, Ridker PM, Goldhaber SZ, et al. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism. Report from the Women's Health Study. Circulation. 2007 Sep 10. [Epub ahead of print]
- Reviewer: EBSCO CAM Review Board
- Review Date: 08/2013 -
- Update Date: 00/72/2014 -